Cargando…
Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study
BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease and is one of the most costly medical conditions that imposed families with catastrophic health expenditures. There is an increasing trend in using alternative medicines including, dietary supplements, herbs, vitamins, and minerals....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406745/ https://www.ncbi.nlm.nih.gov/pubmed/34465284 http://dx.doi.org/10.1186/s12883-021-02357-8 |
_version_ | 1783746549914796032 |
---|---|
author | Ziaie, Shadi Namazi, Niloofar Afzal, Golnaz Barati, Saghar Mohebbi, Rezvaneh Mir, Mahshad Esmaily, Hadi Mehralian, Gholamhossein |
author_facet | Ziaie, Shadi Namazi, Niloofar Afzal, Golnaz Barati, Saghar Mohebbi, Rezvaneh Mir, Mahshad Esmaily, Hadi Mehralian, Gholamhossein |
author_sort | Ziaie, Shadi |
collection | PubMed |
description | BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease and is one of the most costly medical conditions that imposed families with catastrophic health expenditures. There is an increasing trend in using alternative medicines including, dietary supplements, herbs, vitamins, and minerals. To date, the association between dietary as well as herbal supplements and QoL in MS patients is under researched; thus, this study aimed to assess the association between the self-reported supplement used and QoL between MS patients. METHODS: This cross-sectional study was conducted on patients with MS referring to Shahid Kazemi Pharmacy, based in the city of Tehran, Iran, as a national pharmacy providing specialized pharmaceutical products and pharmaceutical care to patients. The Multiple Sclerosis Quality of Life-54 (MSQoL-54) tools was performed to evaluate MS patients QoL. RESULTS: A total number of 382 patients with MS participated in this study. They include 89 (23.3%) men and 293 (76.7%) women, aged 40 ± 10.9 years old. The overall score of the MSQoL-54 questionnaire was 41.58 out of 100. Physical health composite (PHC) and mental health composite (MHC) were 69.60 and 62.99 from 100, respectively. This study revealed that 76.4% of patients used at least one vitamin daily; 92.4% of patients do not receive any herbal product. Vitamin D is the most widely used supplement, followed by calcium, while vitamin C is the least consumed. No correlation was observed regarding supplement use and overall QoL, PHC, or MHC. There were no significant differences between QoL’s dimensions score in patients who used supplements. The results showed that increasing the number of supplements used did not relate to overall QoL, PHC, or MHC. In addition, there was not any correlation between the duration used of supplements and QoL’s dimensions score in MS patients (p-value> 0.05). CONCLUSIONS: The dietary supplement appears to be popular among MS patients. The study results showed that the number of supplementations and their long-term use in patients with MS were not associated with higher QoL. Similarly, the herbal supplements have failed to improve QoL. |
format | Online Article Text |
id | pubmed-8406745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84067452021-08-31 Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study Ziaie, Shadi Namazi, Niloofar Afzal, Golnaz Barati, Saghar Mohebbi, Rezvaneh Mir, Mahshad Esmaily, Hadi Mehralian, Gholamhossein BMC Neurol Research BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease and is one of the most costly medical conditions that imposed families with catastrophic health expenditures. There is an increasing trend in using alternative medicines including, dietary supplements, herbs, vitamins, and minerals. To date, the association between dietary as well as herbal supplements and QoL in MS patients is under researched; thus, this study aimed to assess the association between the self-reported supplement used and QoL between MS patients. METHODS: This cross-sectional study was conducted on patients with MS referring to Shahid Kazemi Pharmacy, based in the city of Tehran, Iran, as a national pharmacy providing specialized pharmaceutical products and pharmaceutical care to patients. The Multiple Sclerosis Quality of Life-54 (MSQoL-54) tools was performed to evaluate MS patients QoL. RESULTS: A total number of 382 patients with MS participated in this study. They include 89 (23.3%) men and 293 (76.7%) women, aged 40 ± 10.9 years old. The overall score of the MSQoL-54 questionnaire was 41.58 out of 100. Physical health composite (PHC) and mental health composite (MHC) were 69.60 and 62.99 from 100, respectively. This study revealed that 76.4% of patients used at least one vitamin daily; 92.4% of patients do not receive any herbal product. Vitamin D is the most widely used supplement, followed by calcium, while vitamin C is the least consumed. No correlation was observed regarding supplement use and overall QoL, PHC, or MHC. There were no significant differences between QoL’s dimensions score in patients who used supplements. The results showed that increasing the number of supplements used did not relate to overall QoL, PHC, or MHC. In addition, there was not any correlation between the duration used of supplements and QoL’s dimensions score in MS patients (p-value> 0.05). CONCLUSIONS: The dietary supplement appears to be popular among MS patients. The study results showed that the number of supplementations and their long-term use in patients with MS were not associated with higher QoL. Similarly, the herbal supplements have failed to improve QoL. BioMed Central 2021-08-31 /pmc/articles/PMC8406745/ /pubmed/34465284 http://dx.doi.org/10.1186/s12883-021-02357-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ziaie, Shadi Namazi, Niloofar Afzal, Golnaz Barati, Saghar Mohebbi, Rezvaneh Mir, Mahshad Esmaily, Hadi Mehralian, Gholamhossein Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study |
title | Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study |
title_full | Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study |
title_fullStr | Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study |
title_full_unstemmed | Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study |
title_short | Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study |
title_sort | assessing multiple sclerosis-related quality of life among iranian patients using the msqol-54 tool: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406745/ https://www.ncbi.nlm.nih.gov/pubmed/34465284 http://dx.doi.org/10.1186/s12883-021-02357-8 |
work_keys_str_mv | AT ziaieshadi assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT namaziniloofar assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT afzalgolnaz assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT baratisaghar assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT mohebbirezvaneh assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT mirmahshad assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT esmailyhadi assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy AT mehraliangholamhossein assessingmultiplesclerosisrelatedqualityoflifeamongiranianpatientsusingthemsqol54toolacrosssectionalstudy |